Land: Bandaríkin
Tungumál: enska
Heimild: NLM (National Library of Medicine)
LOSARTAN POTASSIUM (UNII: 3ST302B24A) (LOSARTAN - UNII:JMS50MPO89)
Micro Labs Limited
LOSARTAN POTASSIUM
LOSARTAN POTASSIUM 25 mg
ORAL
PRESCRIPTION DRUG
Losartan potassium tablets are indicated for the treatment of hypertension in adults and pediatric patients 6 years of age and older, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and nonfatal cardiovascular (CV) events, primarily strokes and myocardial infarction. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including losartan. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than 1 drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC). Numerous antihypertensive
Losartan Potassium USP 25 mg tablets are white to off-white, oval shaped, film-coated tablets with “A” engraved on one side and “25” on the other side. They are supplied as follows: NDC 42571-110-30 unit of use bottles of 30 NDC 42571-110-90 unit of use bottles of 90 NDC 42571-110-10 unit of use bottles of 1000 Losartan Potassium USP 50 mg tablets are white to off-white, oval shaped, film-coated tablets with “A50” engraved on one side and break line on the other side. They are supplied as follows: NDC 42571-111-30 unit of use bottles of 30 NDC 42571-111-90 unit of use bottles of 90 NDC 42571-111-10 unit dose packages of 1000 Losartan Potassium USP 100 mg tablets are white to off-white, oval shaped, film-coated tablets with “A100” engraved on one side and plain on the other side. They are supplied as follows: NDC 42571-112-30 unit of use bottles of 30 NDC 42571-112-90 unit of use bottles of 90 NDC 42571-112-10 unit dose packages of 1000 Store at 25ºC (77ºF); excursions permitted to 15 to 30ºC (59 to 86ºF) [see USP Controlled Room Temperature]. Keep container tightly closed. Protect from light.
Abbreviated New Drug Application
LOSARTAN POTASSIUM- LOSARTAN POTASSIUM TABLET, FILM COATED MICRO LABS LIMITED ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE LOSARTAN POTASSIUM TABLETS SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM TABLETS, FOR ORAL USE INITIAL U.S. APPROVAL: 1995 WARNING: FETAL TOXICITY _SEE FULL PRESCRIBING INFORMATION FOR COMPLETE BOXED WARNING._ WHEN PREGNANCY IS DETECTED, DISCONTINUE LOSARTAN POTASSIUM AS SOON AS POSSIBLE. DRUGS THAT ACT DIRECTLY ON THE RENIN-ANGIOTENSIN SYSTEM CAN CAUSE INJURY AND DEATH TO THE DEVELOPING FETUS. ( 5.1) INDICATIONS AND USAGE Losartan potassium tablet is an angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension, to lower blood pressure in adults and children greater than 6 years old. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1) Reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy. There is evidence that this benefit does not apply to Black patients. ( 1.2) Treatment of diabetic nephropathy with an elevated serum creatinine and proteinuria in patients with type 2 diabetes and a history of hypertension. ( 1.3) DOSAGE AND ADMINISTRATION Hypertension Usual adult dose: 50 mg once daily. ( 2.1) Usual pediatric starting dose: 0.7 mg per kg once daily (up to 50 mg). ( 2.1) Hypertensive Patients with Left Ventricular Hypertrophy Usual starting dose: 50 mg once daily. ( 2.2) Add hydrochlorothiazide 12.5 mg and/or increase losartan potassium to 100 mg followed by an increase to hydrochlorothiazide 25 mg if further blood pressure response is needed. ( 2.2, 14.2) Nephropathy in Type 2 Diabetic Patients Usual dose: 50 mg once daily. ( 2.3) Increase dose to 100 mg once daily if further blood pressure response is needed. ( 2.3) DOSAGE FORMS AND STRENGTHS Tablets: 25 mg; 50 mg; and 100 mg. ( 3) CONTRAINDICATIONS Hypersensitiv Lestu allt skjalið